If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
3mg
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
What is the mechanism of action for Baqsimi™ (glucagon) nasal powder?
Glucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating hepatic glycogen breakdown and release of glucose from the liver.
Mechanism of Action
Glucagon increases blood glucose concentration by activating hepatic glucagon receptors, thereby stimulating hepatic glycogen breakdown and release of glucose from the liver.1
Hepatic stores of glycogen are necessary for glucagon to produce an antihypoglycemic effect.1
Enclosed Prescribing Information
Reference
1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Date of Last Review: November 08, 2021